Nomura Holdings’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,207
| Closed | -$409K | – | 1750 |
|
|
2022
Q1 | $409K | Buy |
1,207
+252
| +26% | +$85.4K | ﹤0.01% | 931 |
|
|
2021
Q4 | $344K | Sell |
955
-517
| -35% | -$186K | ﹤0.01% | 1169 |
|
|
2021
Q3 | $476K | Buy |
1,472
+225
| +18% | +$72.8K | ﹤0.01% | 1055 |
|
|
2021
Q2 | $389K | Buy |
+1,247
| New | +$389K | ﹤0.01% | 1112 |
|
|
2021
Q1 | – | Sell |
-1,634
| Closed | -$530K | – | 1821 |
|
|
2020
Q4 | $530K | Buy |
1,634
+516
| +46% | +$167K | ﹤0.01% | 839 |
|
|
2020
Q3 | $310K | Sell |
1,118
-2,079
| -65% | -$576K | ﹤0.01% | 779 |
|
|
2020
Q2 | $772K | Buy |
+3,197
| New | +$772K | ﹤0.01% | 522 |
|
|
2020
Q1 | – | Sell |
-5,326
| Closed | -$909K | – | 890 |
|
|
2019
Q4 | $909K | Sell |
5,326
-1,312
| -20% | -$224K | ﹤0.01% | 486 |
|
|
2019
Q3 | $1.13M | Sell |
6,638
-1,071
| -14% | -$183K | ﹤0.01% | 461 |
|
|
2019
Q2 | $2.04M | Buy |
7,709
+3,765
| +95% | +$998K | 0.01% | 393 |
|
|
2019
Q1 | $1.1M | Sell |
3,944
-59,751
| -94% | -$16.6M | ﹤0.01% | 510 |
|
|
2018
Q4 | $20.7M | Sell |
63,695
-3,704
| -5% | -$1.2M | 0.08% | 94 |
|
|
2018
Q3 | $30M | Sell |
67,399
-6,136
| -8% | -$2.73M | 0.11% | 84 |
|
|
2018
Q2 | $30.1M | Buy |
73,535
+69,073
| +1,548% | +$28.3M | 0.1% | 83 |
|
|
2018
Q1 | $1.3K | Buy |
+4,462
| New | +$1.3K | ﹤0.01% | 632 |
|
|
2017
Q3 | – | Sell |
-6,193
| Closed | -$888K | – | 1141 |
|
|
2017
Q2 | $888K | Buy |
+6,193
| New | +$888K | ﹤0.01% | 702 |
|
|
2015
Q1 | – | Sell |
-9,169
| Closed | -$337K | – | 1685 |
|
|
2014
Q4 | $337K | Buy |
+9,169
| New | +$337K | ﹤0.01% | 1109 |
|
|
2014
Q3 | – | Sell |
-8,871
| Closed | -$221K | – | 2150 |
|
|
2014
Q2 | $221K | Sell |
8,871
-3,170
| -26% | -$79K | ﹤0.01% | 1557 |
|
|
2014
Q1 | $316K | Buy |
+12,041
| New | +$316K | ﹤0.01% | 1369 |
|
|
2013
Q3 | – | Sell |
-17,559
| Closed | -$379K | – | 2559 |
|
|
2013
Q2 | $379K | Buy |
+17,559
| New | +$379K | ﹤0.01% | 1397 |
|